January 23, 2019 / 12:54 PM / 6 months ago

Abbott Lab's fourth-quarter revenue rises 2.3 pct

Jan 23 (Reuters) - Abbott Laboratories posted a 2.3 percent rise in fourth-quarter revenue on Wednesday, helped by growing demand for its heart valves and glucose monitoring devices.

The company posted net earnings of $654 million, or 37 cents per share, in the fourth quarter ended Dec. 31, from a loss of $828 million, or 48 cents per share, a year earlier, when it had taken a $1.4 billion charge related to changes to the U.S. tax law.

Net sales of the diversified healthcare company rose to $7.77 billion from $7.59 billion. (Reporting by Manas Mishra in Bengaluru Editing by Saumyadeb Chakrabarty)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below